Definium Therapeutics DFTX
NASDAQ DFTX
$36.00 +0.51 (+1.44%)
At close: Oct 22, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Price to Sales (2022 - 2023)

Updated

Analysis

Definium Therapeutics (DFTX) Price to Sales (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Definium Therapeutics 3.99 Bn 1.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 32.26
Sep 30, 2023 26.09
Jun 30, 2023 34.57
Mar 31, 2023 43.69
Dec 31, 2022 46.28
Sep 30, 2022 371.51
API Access

Definium Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=DFTX&period=max&api_key=YOUR_API_KEY